Gene expression of plasminogen activation cascade components in human term gestational tissues with labour onset

Molecular Human Reproduction

Volumn 4, Issue 1, 1998, Pages 101-106

  Tsatas, D ^a   Baker, M S ^b   Moses, E K ^a   Rice, G E ^a  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Gene expression; Plasminogen activator inhibitor 2; Urokinase plasminogen activator; Urokinase receptor

Indexed keywords

PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 2; UROKINASE; UROKINASE RECEPTOR;

AMNION; ARTICLE; CELL SURFACE; CHORION; DECIDUA; FEMALE; FETUS MEMBRANE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LABOR; NORTHERN BLOTTING; PLACENTA; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; SEQUENCE ANALYSIS;

AMNION; FEMALE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LABOR ONSET; LABOR, OBSTETRIC; PLACENTA; PLASMINOGEN ACTIVATOR INHIBITOR 2; PLASMINOGEN ACTIVATORS; PREGNANCY; RECEPTORS, CELL SURFACE; RNA, MESSENGER; UP-REGULATION; URINARY PLASMINOGEN ACTIVATOR;

EID: 0031912275     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/4.1.101     Document Type: Article

References (39)

1. Al-Zaid, N.S., Gumaa, K.A., Bou-Resli, M.N. et al. (1986) Site variability in the solubility of collagen of human fetal membranes. J. Reprod. Fertil., 77, 665-668.
2. Behrendt, N., Ronne, E. and Dano, K. (1995) The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface. Biol. Chem. Hoppe-Seyler, 376, 269-279.
3. Bischof, P. and Martelli, M. (1992) Current topic: Proteolysis in the penetration phase of the implantation process. Placenta, 13, 17-24.
4. Blasi, F. (1993) Urokinase and urokinase receptor - a paracrine/autocrine system regulating cell migration and invasiveness. BioEssays, 15, 105-111.
5. Bonnar, J., Daly, L. and Sheppard, B.L. (1990) Changes in the fibrinolytic system during pregnancy. Sem. Thromb. Hemost., 16, 221-229.
6. Burgos, H., Hsi, B.L., Yeh, C.J.G. et al. (1982) Plasminogen binding by human amniochorion. A possible factor in premature rupture of membranes. Am. J Obstet. Gynecol., 143, 958-963.
7. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
8. Conese, M. and Blasi, F. (1995) Urokinase/urokinase receptor system: internalisation/degradation of urokinase-serpin complexes: mechanism and regulation. Biol Chem. Hoppe-Seyler, 376, 143-155.
9. Emonard, H. and Grimaud, J.A. (1990) Matrix metalloproteases. A review. Cell. Mol. Biol., 36, 131-153.
10. Feinberg, R.F., Kao, L.C., Haimowitz, J.E. et al. (1989) Plasminogen activator inhibitor types 1 and 2 in human trophoblasts. PAI-1 is an immunocytochemical marker of invading trophoblasts. Lab. Invest., 61, 20-26.
11. Granstrom, L.M., Ekman, G.E., Malmstrom, A. et al. (1992) Serum collagenase levels m relation to the state of the human cervix during pregnancy and labour. Am. J. Obstet. Gynecol., 167, 1284-1288.
12. Ibrahim, M.E.A., Bou-Resh, M.N., Al-Zaid, N.S. et al. (1983) Intact fetal membranes. Morphological predisposai to rupture. Acta Obstet. Gyynaecol. Scand., 62, 481-485.
13. Jeffrey, J J. (1991) Collagen and collagenase:pregnancy and parturition. Semin. Perinatol., 15, 118-126.
14. Jenkins, D.M., O'Neill, M., Mattar, M. et al. (1983) Degenerative changes and detection of plasminogen in fetal membranes that rupture prematurely. Br. J. Obstet. Gynaecol., 90, 841-846.
15. Kliman, H.J (1994) Trophoblast infiltration. Reprod. Med. Rev., 3, 137-157.
16. Koh, S.C L., Anandakumar, C., Arulkumaran, S. et al. (1995) Amniotic fluid plasminogen activators and inhibitors and tat-complex levels during 2nd trimester pregnancy. Fibrinolysis, 9, 121-126.
17. Lei, H., Furth, E.E., Kalluri, R. et al. (1996) A program of cell death and extracellular matrix degradation is activated in the amnion before the onset of labor. J. Clin. Invest., 98, 1971-1978.
18. Librach, C.L., Feigenbaum, S.L., Bass, K.E. et al. (1994) Interleukin-1 beta regulates human cytotrophoblast metalloproteinase activity and invasion in vitro. J. Biol. Chem., 269, 17125-17131
19. Lindoff, C., Lecander, I. and Astedt, B. (1993) Fibrinolytic components in individual consecutive plasma samples during normal pregnancy. Fibrinolysis, 7, 190-194.
20. Littlefield, B.A. (1992) Plasminogen activators in endometrial physiology and embryo implantation: a review. Ann. NY Acad. Sci., 167-175.
21. Multhaupt, H.A.B., Mazar, A., Cines, D.B. et al. (1994) Expression of urokinase receptors by human trophoblasts. A histochemical and ultrastructural analysis. Lab. Invest., 71, 392-400.
22. Queenan, J.T., Kao, L C, Arboleda, C.E. et al. (1987) Regulation of urokinase type plasminogen activator production by cultured human cytotrophoblasts. J. Biol. Chem., 262, 10903-10906.
23. Rajabi, M.R., Dean, D.D., Beydoun, S.N. et al. (1988) Elevated tissue levels of collagenase during dilation of utrine cervix in human parturition. Am. J. Obstet. Gynecol., 159, 971-976.
24. Riccio, A., Grimaldi, G., Verde, P. et al. (1985) The human urokinase-plasminogen activator gene and its promoter Nucl. Acid Res., 13, 2759-2771.
25. Ries, C. and Petrides, P.E. (1995) Cytokine regulation of matrix metalloprorease activity and its regulatory dysfunction in disease. Biol. Chem. Hoppe-Seyler, 376, 345-355.
26. Roldan, A.L., Cubellis, M.V., Masucci, M.T. et al. (1990) Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J., 9, 467-474.
27. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning - A Laboratory Manual, 2nd edn. Cold Spring Harbour Laboratory Press, New York.
28. Sanger, F., Nicklen, S. and Coulson, A.R. (1977) DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad., Sci. USA, 74, 5463-5467.
29. Sappino, A.P., Huarte, J., Belin, D. et al. (1989) Plasminogen activators in tissue remodeling and invasion: mRNA localisation in mouse ovaries and implanting embryos. J. Cell Biol., 109, 2471-2479.
30. Schleuning, W.D., Medcalf, R L., Hession, C. et al. (1987) Plasminogen activator inhibitor 2: Regulation of gene transcription during phorbol estermediated differentiation of U-937 human histiocytic lymphoma cells. Mol. Cell. Biol., 7, 4564-4567
31. Schmitt, M., Wilhelm, O., Janicke, F. et al. (1995) Urokinase-type plasminogen activator (uPA) and its receptor (CD87): a new target in tumour invasion and metastasis. J. Obstet. Gynecol., 21, 151-165.
32. So, T., Ito, A., Sato, T. et al. (1992) Tumour necrosis factor-α stimulates the biosynthesis of matrix metalloproteinases and plasminogen activator in cultured human chorionic cells. Biol. Reprod., 46, 772-778.
33. Strickland, S., Reich, E and Sherman, M.I. (1976) Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm. Cell, 9, 231-240.
34. Tsatas, D., Baker, M.S. and Rice, G.E. (1997) Tissue-specific expression of the relaxed conformation of plasminogen activator inhibitor-2 and low density lipoprotein receptor-related protein in human term gestational tissues. J. Histochem. Cytochem., in press.
35. Uszynski, M., Uszynski, W. and Kielkoski, A. (1995) Tissue plasminogen activator and plasminogen activator inhibitors of types 1 and 2 in amniotic fluid before labour and after childbirth. Gynecol. Obstet. Invest., 39, 93-96.
36. Vadillo-Ortega, F., Gonzalez-Avila, G., Furth, E.E. et al. (1995) 92-kd type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labour. Am. J. Pathol., 146, 148-156.
37. Watanabe, T., Araki, M., Mimuro, J et al. (1993) Fibrinolytic components in fetal membranes and amniotic fluid. Am. J. Obstet. Gynecol., 168, 1283-1289.
38. Yeh, I.T. and Kurman, R.J. (1989) Functional and morphologic expressions of trophoblast. Lab. Invest., 61, 1-4.
39. Zini, J.M., Murray, S.C., Graham, C.H et al. (1992) Characterisation of urokinase receptor expression by human placental trophoblasts. Blood, 79, 2917-2929.